In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pharmacyclics Inc.

Division of AbbVie Inc.

Latest From Pharmacyclics Inc.

Asia Executives On The Move: Merck, Novo Nordisk, Ascentage

Merck China R&D head leaving after overseeing several high-profile drug approvals, while Novo Nordisk China's marketing head will lead the firm's operations in Oceania.
Appointments Asia Pacific

Natco-Alvogen Claim First Filer ANDA Status For Imbruvica Tablet Form

Natco and Alvogen Pine Brook have entered the arena for a potential generic version of AbbVie/Johnson & Johnson’s Imbruvica through a US ANDA filing for the tablet version of the BTK-inhibitor.
Policy & Regulation Generic Drugs

AbbVie’s Downward Humira Guidance Worries Analysts

Decreasing Humira’s ex-US sales guidance for the second time in three months caught significant attention, as AbbVie now expects 30% revenue erosion for its top-seller outside its home market.

Sales & Earnings Commercial

Interview: Summit Hits The Heights With Billionaire Backing

Ex-Pharmacyclics CEO Bob Duggan is to invest $25m into Summit Therapeutics, taking a near 49% stake in the UK firm and helping it fund Phase III trials for the Oxford-based firm's lead antibiotic candidate ridinilazole.

Infectious Diseases Financing
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • AbbVie Inc.
  • Senior Management
  • Robert W Duggan, Chmn. & CEO
    Manmeet Soni, CFO
    Maky Zanganeh, COO
    Wulff-Erik von Borcke, Pres.
  • Contact Info
  • Pharmacyclics Inc.
    Phone: (408) 774-0330
    995 E. Arques Ave.
    Sunnyvale, CA 94085